AKESOgen is a biomarker, genomics and pharmacogenomics CRO company that services the academic, pharmaceutical, biotechnology and agricultural sectors. The company is based in Atlanta, GA, USA. AKESOgen performs biomarker profiling and genomics services (e.g. next generation sequencing and genotyping) utilizing different types of markers (e.g. DNA, mRNA, miRNA, methylation) for the R&D market. AKESOgen establishes and validates biomarkers in the Clinical Trials arena. AKESOgen has expertise in Biobanking.
Type
Private
HQ
Norcross, US
Founded
2010
Size (employees)
25 (est)+5%
AKESOgen was founded in 2010 and is headquartered in Norcross, US
Report incorrect company information

AKESOgen Office Locations

AKESOgen has an office in Norcross
Norcross, US (HQ)
3155 Northwoods Pl NW
Show all (1)
Report incorrect company information

AKESOgen Financials and Metrics

Summary Metrics

Founding Date

2010

Total Funding

$1.5 m

Latest funding size

$1.31 m

Time since last funding

4 years ago
AKESOgen's latest funding round in January 2014 was reported to be $1.3 m. In total, AKESOgen has raised $1.5 m
Show all financial metrics
Report incorrect company information

AKESOgen Online and Social Media Presence

Embed Graph
Report incorrect company information

AKESOgen News and Updates

Cytox in Collaboration with AKESOgen Extends Genetic Test for Assessing Alzheimer’s Risk to Include Saliva Samples

PRESS RELEASE: Cytox, a precision medicine testing company commercializing polygenic risk scoring (PRS) and other approaches for assessing genetic risk for developing Alzheimer's disease, has collaborated with integrated genomics and genetics leader...
Report incorrect company information